Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA)

42 filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share as of Q2 2021.
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36,699,886 shares of 84,213,667 outstanding shares and own 43.58% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5,694,841 shares), NEA Management Company, LLC (5,108,563 shares), RA CAPITAL MANAGEMENT, L.P. (5,100,000 shares), WELLINGTON MANAGEMENT GROUP LLP (3,911,840 shares), Vivo Capital, LLC (3,048,507 shares), PERCEPTIVE ADVISORS LLC (2,888,889 shares), Abingworth LLP (2,457,499 shares), Aisling Capital Management LP (1,332,485 shares), Samsara BioCapital, LLC (1,111,112 shares), and Foresite Capital Management III, LLC (1,111,112 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.